BMC Cardiovascular Disorders

Scope & Guideline

Pioneering research for a healthier heart.

Introduction

Welcome to your portal for understanding BMC Cardiovascular Disorders, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1471-2261
PublisherBMC
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationBMC CARDIOVASC DISOR / BMC Cardiovasc. Disord.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

BMC Cardiovascular Disorders is a journal dedicated to the exploration and dissemination of research related to cardiovascular health, diseases, and treatments. Its primary aim is to provide a platform for the publication of high-quality research that contributes to the understanding and management of cardiovascular disorders across various populations and clinical settings.
  1. Cardiovascular Disease Epidemiology:
    The journal focuses on the epidemiological aspects of cardiovascular diseases, including the prevalence, risk factors, and outcomes associated with different cardiovascular conditions in diverse populations.
  2. Clinical Management and Therapeutic Interventions:
    Research on clinical management strategies, including pharmacological treatments, surgical procedures, and rehabilitation programs for various cardiovascular disorders, is a key focus area.
  3. Diagnostic and Prognostic Biomarkers:
    The journal emphasizes the development and validation of biomarkers for the diagnosis, prognosis, and risk stratification of cardiovascular diseases, improving clinical outcomes through personalized medicine.
  4. Innovative Technologies and Methodologies:
    BMC Cardiovascular Disorders publishes studies that employ advanced technologies such as imaging techniques, bioinformatics, and machine learning to enhance the understanding and treatment of cardiovascular conditions.
  5. Patient-Centered Care and Quality of Life:
    Research addressing patient experiences, self-management strategies, and quality of life in individuals with cardiovascular diseases is a significant area of interest.
BMC Cardiovascular Disorders has witnessed a dynamic evolution in its thematic focus, reflecting current trends and emerging areas of interest in cardiovascular research. This section highlights the prominent themes that have gained traction in recent years.
  1. Digital Health and Telemedicine:
    With the rise of digital health technologies, there is an increasing number of studies exploring telemedicine, mobile health applications, and remote monitoring as effective strategies for managing cardiovascular diseases.
  2. Comorbidities and Multimorbidity:
    Research exploring the interplay between cardiovascular diseases and other chronic conditions, such as diabetes, obesity, and mental health disorders, is gaining prominence, reflecting a holistic approach to patient care.
  3. Genomics and Personalized Medicine:
    There is a growing trend towards studies that investigate the genetic underpinnings of cardiovascular diseases, aiming to develop personalized treatment strategies based on genetic profiles.
  4. Inflammation and Immune Response:
    Research focusing on the role of inflammation and immune responses in cardiovascular diseases is becoming more prevalent, highlighting the importance of these factors in disease progression and management.
  5. Machine Learning and Artificial Intelligence:
    The application of machine learning and AI in predicting cardiovascular outcomes and optimizing treatment protocols is emerging as a significant area of research, indicating a shift towards data-driven approaches in cardiology.

Declining or Waning

While the journal has consistently published impactful research in various areas of cardiovascular health, certain themes have shown a declining trend in recent publications. This may indicate a shift in focus towards emerging areas or a saturation of previously popular topics.
  1. Traditional Risk Factor Studies:
    There has been a noticeable decline in studies focusing solely on traditional cardiovascular risk factors such as cholesterol levels, blood pressure, and smoking, as newer research emphasizes more complex interactions and comorbidities.
  2. Basic Science Research:
    Research articles centered on purely basic science aspects of cardiovascular disorders, such as cellular and molecular mechanisms, have decreased, possibly due to a growing preference for translational and clinical research.
  3. Invasive Procedures:
    There appears to be a waning interest in studies exclusively focused on invasive procedures for cardiovascular intervention, as the field shifts towards less invasive techniques and comprehensive patient management strategies.

Similar Journals

Anatolian Journal of Cardiology

Connecting Global Hearts with Cutting-edge Cardiovascular Knowledge.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

CIRCULATION

Advancing Cardiovascular Insights, One Beat at a Time.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

Cardiology Research and Practice

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

CARDIOLOGY

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: KARGERISSN: 0008-6312Frequency: 6 issues/year

CARDIOLOGY, published by KARGER, is a renowned scholarly journal dedicated to the advancement of research in the fields of cardiology and cardiovascular medicine. Since its inception in 1937, the journal has consistently provided a platform for high-quality, peer-reviewed articles that contribute to the understanding and treatment of heart and vascular diseases. With an impressive convergence through 2024, CARDIOLOGY holds a respectable Q2 ranking in both the Cardiology and Cardiovascular Medicine and Pharmacology (medical) categories, placing it within the 53rd and 45th percentiles of respective Scopus ranks. Based in Switzerland, the journal serves as an essential resource for researchers and practitioners aiming to stay abreast of cutting-edge developments and evidence-based practices in cardiovascular health. While it currently does not offer open access options, its commitment to rigorous scientific standards solidifies its significance within the academic community. We invite readers to explore the latest research findings and contribute to this vital field through publications in CARDIOLOGY.

Frontiers in Cardiovascular Medicine

Fostering Collaboration to Shape the Future of Cardiology.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

Clinica e Investigacion en Arteriosclerosis

Elevating the standards of cardiovascular medicine through rigorous investigation.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Cardiology Journal

Empowering global research in cardiology.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

International Cardiovascular Research Journal

Innovating heart health through rigorous research.
Publisher: SHIRAZ UNIV MEDICAL SCIENCES, CARDIOVASCULAR RESEARCH CENTERISSN: 2251-9130Frequency: 4 issues/year

International Cardiovascular Research Journal, published by Shiraz University Medical Sciences, serves as a vital platform for the dissemination of cutting-edge research in the field of cardiology and cardiovascular medicine. Since its inception in 2011, this journal has continuously devoted itself to promoting the highest quality of scholarly communication, helping to bridge the gap between laboratory findings and clinical application. With an ISSN of 2251-9130 and an E-ISSN of 2251-9149, it is indexed in prominent databases, contributing to its visibility and accessibility to a global audience. Although currently classified in the Q4 quartile in the 2023 rankings, the journal is committed to enhancing its impact factor and academic stature. It aims to facilitate open access for all published articles, although specific details on access options are pending. Through its rigorous peer-review process and diverse scope—which encapsulates advancements, clinical studies, and innovative therapeutic strategies—this journal fosters academic collaboration in the realm of cardiovascular health, making it an invaluable resource for researchers, practitioners, and students alike.

Research in Cardiovascular Medicine

Shaping the future of cardiovascular medicine through open access.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2251-9572Frequency: 4 issues/year

Research in Cardiovascular Medicine is a renowned open-access journal published by Wolters Kluwer Medknow Publications, dedicated to advancing knowledge in the swiftly evolving field of cardiovascular health. With an ISSN of 2251-9572 and E-ISSN of 2251-9580, this journal serves as a vital platform for researchers and professionals to share their findings, explore innovative treatments, and discuss current trends in cardiovascular care. Since transitioning to open access in 2013, it has democratized access to high-quality research, ensuring that vital information reaches healthcare practitioners and academia alike. The journal’s commitment to rigorous peer review and its emphasis on cutting-edge research contribute significantly to improving patient outcomes and addressing the global burden of cardiovascular diseases. By publishing original articles, review papers, and clinical studies, Research in Cardiovascular Medicine plays a crucial role in shaping the future of cardiovascular research and education, appealing to a wide audience of researchers, professionals, and students striving to make meaningful contributions to this critical field.

Acta Cardiologica Sinica

Connecting Researchers for a Stronger Cardiac Future.
Publisher: TAIWAN SOC CARDIOLOGYISSN: 1011-6842Frequency: 4 issues/year

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.